Gary H. Lyman
Impact in
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 0.01%
- Neutropenia and Cancer Infections
- Cutaneous Melanoma Detection and Management
- Cancer survivorship and care
Papers in
- Oncology 346
- Neutropenia and Cancer Infections 208
- Cancer Treatment and Pharmacology 78
-
- Health Systems, Economic Evaluations, Quality of Life 55
- Economic and Financial Impacts of Cancer 54
- Co-authors
- Nicole M. Kuderer (114 shared papers)Alok A. Khorana (52 shared papers)David C. Dale (59 shared papers)Eva Culakova (69 shared papers)Jeffrey Crawford (44 shared papers)Charles W. Francis (21 shared papers)Lodovico Balducci (23 shared papers)Mark R. Somerfield (19 shared papers)
- Journals
- Journal of Clinical Oncology (134 papers)Blood (45 papers)Cancer (30 papers)Journal of Oncology Practice (24 papers)Journal of the National Comprehensive Cancer Network (20 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Gary H. Lyman
593 papers receiving 47.8k citations
Gary H. Lyman's Hit Papers
Peers
Comparison fields: 5 of 205
- Internal Medicine 8.0k
- Oncology 20.5k
- Cancer Research 5.5k
- Emergency Medical Services 2.1k
- Hematology 3.2k
Countries citing papers authored by Gary H. Lyman
This map shows the geographic impact of Gary H. Lyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary H. Lyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary H. Lyman more than expected).
Fields of papers citing papers by Gary H. Lyman
This network shows the impact of papers produced by Gary H. Lyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary H. Lyman. The network helps show where Gary H. Lyman may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary H. Lyman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 609 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System Hit paper breakdown → | 2001 | 1779 |
| 2 | Development and validation of a predictive model for chemotherapy-associated thrombosis Hit paper breakdown → | 2008 | 1553 |
| 3 | American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Hit paper breakdown → | 2005 | 1373 |
| 4 | Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer Hit paper breakdown → | 1991 | 1114 |
| 5 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 Hit paper breakdown → | 2015 | 971 |
| 6 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Hit paper breakdown → | 2019 | 967 |
| 7 | Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Hit paper breakdown → | 2018 | 885 |
| 8 | Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Hit paper breakdown → | 2006 | 858 |
| 9 | Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2011 | 830 |
| 10 | Recommendations on the Use of 18F-FDG PET in Oncology Hit paper breakdown → | 2008 | 796 |
| 11 | 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours Hit paper breakdown → | 2010 | 788 |
| 12 | Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score Hit paper breakdown → | 2011 | 771 |
| 13 | Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2014 | 767 |
| 14 | Comorbidity and functional status are independent in older cancer patients. Hit paper breakdown → | 1998 | 764 |
| 15 | American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline Hit paper breakdown → | 2015 | 750 |
| 16 | American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer Hit paper breakdown → | 2007 | 721 |
| 17 | Chemotherapy‐induced neutropenia Hit paper breakdown → | 2004 | 654 |
| 18 | Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma Hit paper breakdown → | 2005 | 625 |
| 19 | Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Hit paper breakdown → | 2007 | 610 |
| 20 | Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2015 | 607 |
About Gary H. Lyman
Gary H. Lyman is a scholar working on Oncology, Economics and Econometrics, Internal Medicine, Genetics and Cancer Research, having authored 609 papers that have together received 49.1k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (208 papers), Cancer Treatment and Pharmacology (78 papers), Venous Thromboembolism Diagnosis and Management (77 papers), Health Systems, Economic Evaluations, Quality of Life (55 papers), Economic and Financial Impacts of Cancer (54 papers), Blood disorders and treatments (53 papers), Breast Cancer Treatment Studies (48 papers) and Chemotherapy-related skin toxicity (25 papers). The work is most often cited by research in Internal Medicine (8.0k citations), Oncology (20.5k citations), Cancer Research (5.5k citations), Emergency Medical Services (2.1k citations) and Hematology (3.2k citations). Gary H. Lyman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nicole M. Kuderer, Alok A. Khorana, David C. Dale, Eva Culakova, Jeffrey Crawford, Charles W. Francis, Lodovico Balducci, Mark R. Somerfield, Armando E. Giuliano and Leon E. Cosler. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, Journal of Oncology Practice and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.